Firms, funds, partners, companies and rounds from sworn filings, firm sites and announcements, kept as a graph with a date and a source on every edge. Facts, inferences and estimates are labelled as such. A fund target is never a close, GAV is never dry powder, and a round size is never an investor’s check.

The names on this page are hidden. Create a free account and they fill in. No card, and every figure, date and source on this page is public either way.

Firms / C••••••• C•••••• M••••••••• L••

C••••••• C•••••• M••••••••• L••

Private equity with venture activity · probableLos Angeles, CAc•••••••••.comSEC registered investment adviser

C••••••• Capital is a growth-oriented investment firm focused on building industry-leading healthcare companies.

registered adviser; venture funds are 0% of 4 private funds

Importance
17
moderate
Active deployment
25
moderate
Emerging
0
low
Completeness
63
high
Freshness
99
high
Research priority
10
low
Identity and regulatory footprint
Headquarters
Los Angeles, CAadviserinfo.sec.gov
Office address
11601 WILSHIRE BLVD, SUITE 420, Los Angeles, CA, 90025adviserinfo.sec.gov
Business phone
310-361-1510adviserinfo.sec.gov
SEC adviser type
registered investment adviseradviserinfo.sec.gov
SEC exemption claimed
unknown
Latest Form ADV
Jun 19, 2024
Private funds reported
4 (0 venture capital funds)adviserinfo.sec.gov
Private fund gross assets
$347Madviserinfo.sec.govreported GAV of the funds, the adviser's own number; not fund size, not dry powder
Regulatory AUM
$173Mthe adviser's RAUM, a regulatory measure, never a fund size
Employees
4
business email
info@curewellcapital.comcurewellcapital.compublished by the subject
business phone
310-361-1510adviserinfo.sec.govpublished by the subject
Stated thesis versus observed behaviour
no observed deals yet
Stated (the firm’s website)
Sectors
healthcare, medtech
Stages
not stated or not yet read
Geography
not stated
Check size
not stated; DFX does not estimate checks from round sizes
Observed (from deals on record)
Stage at participation: no observed deals yet
Stage at first entry: no observed deals yet
Sectors: no observed deals yet
lead rate n/afollow-on rate n/anew logos, 12 months 0
Funds and vehicles
2 reported
VehicleTypeVintageLifecycleReported GAVOwnersForm D soldLatest Form D
C••••••• C•••••• T•••• S••• L•SPV or co-invest vehicle · ADV: Private Equity Fund2024 adv first reportedEarly deployment$22.3M
Jun 19, 2024
11$0Feb 28, 2023
O•••• C•••••• D•• S••• L•SPV or co-invest vehicle · ADV: Private Equity Fund2021 form d first saleMature$151M
Jun 19, 2024
10$131M
of $131M
Dec 21, 2021
GAV is the gross asset value the adviser reported on Form ADV for the vehicle, never the fund’s committed size and never dry powder. Form D sold is the amount sold as of the latest filing, never a final close.
Investment team
3 current, 0 departed
Investments on record
0 edges, 0 companies, 0 partner-attributed
No investment on record yet. Edges arrive from the firm’s portfolio page, financing announcements, and Form D board seats.
Co-investors
0 relationships from shared deals, counted for the whole firm
No co-investor relationship yet: these are derived only from rounds and portfolio listings the graph has seen both investors on.
Limited partners
0 disclosed
No LP commitment on record. An LP edge needs a public disclosure with a quote: a pension report (see Limited partners for the plans read), a fund announcement naming the LP, or a Form ADV owner. The fund page carries the LP’s reported performance.
Timeline
3 dated events
  1. Mar 21, 2024
    C••••••• C•••••• T•••• S••• L• first reported on Form ADV by C••••••• C•••••• M••••••••• L•• (Private Equity Fund), GAV $22,254,258
  2. Feb 2, 2022
    O•••• Capital Management, LLC first filed Form ADV (ERA)
  3. Feb 2, 2022
    O•••• C•••••• D•• S••• L• first reported on Form ADV by O•••• Capital Management, LLC (Private Equity Fund), GAV $131,050,000
Classification history
  1. Sep 12, 2026
    Private equity with venture activity (probable, 75%, cls-1)
    registered adviser; venture funds are 0% of 4 private funds
Evidence
35 observations from 2 sources
Every observation behind this profile, with its source, date and class
FactValueEffectiveClassSource
SEC adviser typeregistered_investment_adviserJun 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
First Form ADV filing2022-02-02Jun 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Adv history loadedadv-hist-1Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Latest Form ADV filing2024-06-19Jun 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Venture share of reported funds0Jun 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Business phone310-361-1510Jun 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Contact page urlhttps://c•••••••••.com/
contact page linked from the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
DescriptionC••••••• Capital is a growth-oriented investment firm focused on building industry-leading healthcare companies.
meta description
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
DescriptionC••••••• Capital is a growth-oriented investment firm focused on building industry-leading healthcare companies.
meta description
Sep 15, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Employees4Jun 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
HeadquartersLos Angeles, CAJun 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Office address11601 WILSHIRE BLVD, SUITE 420, Los Angeles, CA, 90025Jun 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Portfolio pagehttps://c•••••••••.com/
1 entries read
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Portfolio pagehttps://c•••••••••.com/
1 entries read
Sep 15, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Private funds reported4Jun 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Private fund gross assets (reported)$347MJun 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Regulatory AUM (adviser, not fund size)$173MJun 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Stated sectorshealthcare,medtech
sector words on the home page
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Stated sectorshealthcare,medtech
sector words on the home page
Sep 15, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://c•••••••••.com/
1 name/title pairs read
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Team pagehttps://c•••••••••.com/
1 name/title pairs read
Sep 15, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Venture funds reported0Jun 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Websitehttps://c•••••••••.com/
re-picked from Schedule D 1.I by name
Sep 12, 2026FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Websitehttps://c•••••••••.com/Jun 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Websitehttp://www.osugicapital.comJun 19, 2024FactSEC Form ADV filing data 2011 to 2024 (every filing, Schedule D 7.B.(1) private funds, Schedules A/B)
Site titleC••••••• Capital | Empowering Healthcare Growth & Innovation
title tag
Sep 16, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)
Site titleC••••••• Capital | Empowering Healthcare Growth & Innovation
title tag
Sep 15, 2026FactVenture organization websites (about, team, portfolio, thesis, news pages)